| 
			
				 作者ycli6921 
				真實世界的數據看起來像這樣 
同樣是康復組 兩個gmt就不一樣94 vs 48 
採樣時間年齡組劑量也會影響 
 
 
 
50% SARS-CoV-2-neutralizing GMT 
• Placebo: 10; HCS: 94 
• BNT162b1 (18 – 55 y vs. 65 – 85 y) 
o D0: 10 vs. 10 
o D21: 29 vs. 12 
o D28: 267 vs. 101 
o D35: 437 vs. 105 
• BNT162b2 (18 – 55 y vs. 65 – 85 y) 
o D0: 10 vs. 10 
o D21: 14 vs. 12 
o D28: 361 vs. 149 
o D35: 163 vs. 206 
 
 
 
Anti-SARS-CoV-2-spike binding antibody levels 
Day 43 (14 d after dose 2) 
≥18-<55 y old cohort, GM mean (95% CI) peak levels 
• 50 mcg: 189 (173-207) 
• 100 mcg: 239 (221-259) 
• Convalescent plasma: 48 (38-60) 
≥55 y old cohort, GM mean (95% CI) peak levels 
• 50 mcg: 153 (135-175) 
• 100 mc... 
			
		 |